分子診斷市場規模、佔有率、成長分析（按產品、按檢測類型、按樣本類型、按技術、按應用、按最終用戶、按地區）- 行業預測 2025-2032

2023 年全球分子診斷市場規模為 158 億美元，預計將從 2024 年的 168.9 億美元成長到 2032 年的 288 億美元，預測期內（2025-2032 年）的複合年成長率為 6.9%。

隨著技術進步、感染疾病流行率的上升以及個人化醫療的興起，全球分子診斷市場預計將顯著成長。此領域涵蓋與多種疾病相關的生物分子的檢測和表徵，包括感染疾病、腫瘤學、遺傳性疾病和藥物基因組學。 PCR、NGS 和微陣列等最新技術創新提高了測試的敏感性和特異性，從而可以更快、更準確地進行診斷。由於愛滋病毒和肝炎等感染疾病的增加、人口老化以及慢性病的流行，市場正在顯著成長，這些疾病都需要可靠的分子診斷來進行早期發現和有針對性的治療。雅培、羅氏和賽默飛世爾等主要企業正積極尋求策略夥伴關係和產品創新，以鞏固其市場地位。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 專利分析
• 監管分析
• 技術分析
• 案例研究

分子診斷市場規模（按產品和複合年成長率） (2025-2032)

• 市場概覽
• 試劑和套件
• 裝置
• 服務和軟體

分子診斷市場規模（按測試類型和複合年成長率） (2025-2032)

• 市場概覽
• 實驗室篩檢
• POC 測試

分子診斷市場規模（按樣本類型和複合年成長率） (2025-2032)

• 市場概覽
• 血液、血清、血漿
• 尿
• 其他樣本類型

分子診斷市場規模（依技術及複合年成長率） (2025-2032)

• 市場概覽
• 聚合酵素鏈鎖反應
• 恒溫核酸增幅技術
• DNA定序與次世代定序
• 原位雜合技術
• DNA微陣列
• 其他技術

分子診斷市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概覽
• 感染疾病診斷
  • 肝炎
  • B型肝炎
  • C型肝炎
  • 其他肝炎疾病
  • HIV
  • CT/NG
  • 高的
  • HPV
  • 結核
  • 流感
  • 其他感染疾病
• 腫瘤學檢測
  • 乳癌
  • 大腸直腸癌
  • 肺癌
  • 攝護腺癌
  • 其他類型的癌症
• 基因檢測
• 其他用途

分子診斷市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 診斷實驗室
• 醫院和診所
• 其他最終用戶

分子診斷市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• F. Hoffmann-La Roche Ltd.（Switzerland）
• Hologic, Inc.（US）
• Abbott Laboratories（US）
• Illumina, Inc.（US）
• Thermo Fisher Scientific Inc.（US）
• bioMerieux（France）
• QIAGEN（Netherlands）
• Becton Dickinson And Company（US）
• Grifols SA（Spain）
• Bio-Rad Laboratories, Inc.（US）
• Sysmex Corporation（Japan）
• Quidel Corporation（US）
• Biocartis（Belgium）
• DiaSorin（Italy）
• Myriad Genetics（US）
• Revvity（US）
• MDxHealth（Belgium）
• OncoCyte Corporation（US）

結論和建議

Global Molecular Diagnostics Market size was valued at USD 15.8 billion in 2023 and is poised to grow from USD 16.89 billion in 2024 to USD 28.8 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global molecular diagnostics market is poised for significant growth, driven by advancements in technology, increasing prevalence of infectious diseases, and the rise of personalized medicine. This sector encompasses the detection and characterization of biomolecules related to various conditions, including infectious diseases, oncology, genetic disorders, and pharmacogenomics. Recent innovations such as PCR, NGS, and microarrays have enhanced test sensitivity and specificity, enabling quicker and more accurate diagnoses. The market is notably expanding due to rising rates of infectious diseases like HIV and hepatitis, coupled with an aging population and escalating chronic disease prevalence, necessitating reliable molecular diagnostics for early detection and targeted treatments. Key players including Abbott, Roche, and Thermo Fisher are actively pursuing strategic partnerships and product innovations to strengthen their market position.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Molecular Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Molecular Diagnostics Market Segments Analysis

Global Molecular Diagnostics Market is segmented by Product, Test Type, Sample Type, Technology, Application, End User and region. Based on Product, the market is segmented into Reagents & Kits, Instruments and Services & Software. Based on Test Type, the market is segmented into Lab Tests and POC Tests. Based on Sample Type, the market is segmented into Blood, Serum, And Plasma, Urine and Other Sample Types. Based on Technology, the market is segmented into Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, In Situ Hybridization, DNA Microarrays and Other Technologies. Based on Application, the market is segmented into Infectious Disease Diagnostics, Oncology Testing, Genetic Testing and Other Applications. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Molecular Diagnostics Market

The global molecular diagnostics market is being significantly propelled by the rapid advancements in technologies such as Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and microarray technologies. These innovations have transformed the landscape of molecular diagnostics, leading to a marked improvement in the accuracy, sensitivity, and speed of diagnostic tests. As a result, the enhanced performance of these diagnostic tools has fostered greater market growth, enabling healthcare professionals to deliver more precise and timely results. This continuous evolution of diagnostic technology plays a crucial role in expanding the overall molecular diagnostics market, meeting the increasing demand for effective healthcare solutions.

Restraints in the Global Molecular Diagnostics Market

Despite the high accuracy and effectiveness of molecular diagnostic tests, their implementation is often hindered by high costs, particularly in developing regions where healthcare budgets are limited. The expenses associated with the necessary testing equipment, reagents, and the skilled personnel required for molecular testing can be substantial. This financial burden places considerable strain on healthcare facilities in these areas, ultimately restricting the growth of the Global Molecular Diagnostics market. Without addressing these cost-related challenges, widespread adoption and accessibility of molecular diagnostics remain a significant hurdle, hampering potential advancements in patient care and disease management.

Market Trends of the Global Molecular Diagnostics Market

The Global Molecular Diagnostics market is experiencing a significant shift towards point-of-care testing, propelled by the increasing demand for rapid diagnosis and effective treatment monitoring. This trend spans a variety of healthcare environments, including clinics, emergency rooms, and mobile health units, as healthcare providers prioritize timely interventions. Innovations in miniaturized and portable molecular diagnostic devices are facilitating real-time testing outside conventional laboratory settings, thereby improving patient care and operational efficiency. As a result, the market is witnessing an expansion in product offerings and technologies designed to meet the evolving needs of clinicians and patients alike, highlighting a transformative evolution in healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Molecular Diagnostics Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Reagents & Kits
• Instruments
• Services & Software

Global Molecular Diagnostics Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Lab Tests
• POC Tests

Global Molecular Diagnostics Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• Blood, Serum, And Plasma
• Urine
• Other Sample Types

Global Molecular Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Polymerase Chain Reaction
• Isothermal Nucleic Acid Amplification Technology
• DNA Sequencing & Next-Generation Sequencing
• In Situ Hybridization
• DNA Microarrays
• Other Technologies

Global Molecular Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Infectious Disease Diagnostics
  • Hepatitis
  • Hepatitis B
  • Hepatitis C
  • Other hepatitis diseases
  • HIV
  • CT/NG
  • HAI
  • HPV
  • Tuberculosis
  • Influenza
  • Other Infectious Diseases
• Oncology Testing
  • Breast Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancer Types
• Genetic Testing
• Other Applications

Global Molecular Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Diagnostic Laboratories
• Hospitals & Clinics
• Other End Users

Global Molecular Diagnostics Market Size & CAGR (2025-2032)

• North America (Product & Service, Test Type, Sample Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Product & Service, Test Type, Sample Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Test Type, Sample Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Test Type, Sample Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Test Type, Sample Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson And Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocartis (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MDxHealth (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OncoCyte Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations